Immunovant IMVT
NASDAQ IMVT
$33.46 -0.03 (-0.09%)
At close: Sep 29, 2026 · 4:00 PM EDT

Immunovant (IMVT) Non-Current Assets (2018 - 2026)

Updated

Immunovant (IMVT) recorded Non-Current Assets of $1.31 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 86.4% from $9.68 million a year earlier and down 84.0% from the prior quarter.

Analysis

Immunovant (IMVT) Non-Current Assets (2018 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Immunovant reported Non-Current Assets of $8.2 million, down 4.3% from FY2025.

  • Annual Non-Current Assets has a five-year compound annual growth rate of 18.7% (FY2021 to FY2026).
  • Across earlier fiscal years, Non-Current Assets came in at $8.56 million in FY2025, $595,000 in FY2024 (-60.5%), $1.51 million in FY2023 (-42.8%) and $2.63 million in FY2022 (-24.4%).
  • The fiscal Q1 2027 figure is the lowest quarterly Non-Current Assets since fiscal Q1 2025.
  • On a year-over-year basis, Non-Current Assets rose in three of the last five quarters, with growth averaging 153.7%.
  • Peak year-over-year performance for Non-Current Assets in the last five years was growth of 833.4% in fiscal Q2 2025, against a decline of 86.4% in fiscal Q1 2027 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $8.2 million (Q4 2026), $9.45 million (Q3 2026) and $9.41 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Immunovant 6.91 Bn 6.91 Bn - 1.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.31 Mn
Mar 31, 2026 8.20 Mn
Dec 31, 2025 9.45 Mn
Sep 30, 2025 9.41 Mn
Jun 30, 2025 9.68 Mn
Mar 31, 2025 8.56 Mn
Dec 31, 2024 8.39 Mn
Sep 30, 2024 8.34 Mn
Jun 30, 2024 631,000.00
Mar 31, 2024 595,000.00
Dec 31, 2023 670,000.00
Sep 30, 2023 893,000.00
Jun 30, 2023 1.21 Mn
Mar 31, 2023 1.51 Mn
Dec 31, 2022 1.82 Mn
Sep 30, 2022 2.06 Mn
Jun 30, 2022 2.35 Mn
Mar 31, 2022 2.63 Mn
Dec 31, 2021 2.70 Mn
Sep 30, 2021 2.94 Mn
API Access

Immunovant Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=IMVT&period=max&api_key=YOUR_API_KEY